Please login to the form below

Not currently logged in
Email:
Password:

Biogen targets 'lost to follow-up' patients in MS campaign

Biotech company's 1MSg initiative will provide a range of educational materials
Biogen 1MSg campaign

Biogen has launched a new campaign to highlight concerns over the lack of patient engagement with specialist services for multiple sclerosis.

The 1MSg educational initiative offers video advice, an educational website and will see educational materials delivered to GP surgeries and MS centres across the country to help spread the campaign message.

The biotech's 1MSg messaging centres on survey data showing 93% of healthcare professionals with expertise in MS believe that there are people with the condition who are missing out on MS services.

The survey involved around 100 neurologists and nurses and was conducted by Opinion Health on behalf of Biogen.

The poll also found that 97% of those surveyed think there are people who could benefit from reconsidering how they manage their disease in light of how the MS landscape has and continues to evolve.

The campaign, which has a core message of 'take control, know your choices', aims to highlight the benefits of regular and quality engagement with MS-specialists in order to ensure people are making informed decisions about their disease-management.

Dr Martin Duddy is a consultant neurologist specialising in MS and one of a panel of 1MSg clinical experts.

He said: “We know there are a significant number of people with MS who have lost touch with their specialist support team. The danger is that they may be missing out on treatments and care that could help to change the trajectory of their disease, preventing relapses and slowing down progression and disability.

“I want to encourage all people living with MS to regularly see a member of their local MS team.”

Article by
Dominic Tyer

18th February 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...